WO2003059297A8 - Dermatological topical compositions and a process for the preparation thereof - Google Patents

Dermatological topical compositions and a process for the preparation thereof

Info

Publication number
WO2003059297A8
WO2003059297A8 PCT/SK2003/000002 SK0300002W WO03059297A8 WO 2003059297 A8 WO2003059297 A8 WO 2003059297A8 SK 0300002 W SK0300002 W SK 0300002W WO 03059297 A8 WO03059297 A8 WO 03059297A8
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
topical compositions
dermatological topical
substance
dermatological
Prior art date
Application number
PCT/SK2003/000002
Other languages
French (fr)
Other versions
WO2003059297A2 (en
WO2003059297A3 (en
Inventor
Olga Sakova
Ruzena Sochorova
Ivan Varga
Mikulas Lehocky
Original Assignee
Slovakofarma As
Olga Sakova
Ruzena Sochorova
Ivan Varga
Mikulas Lehocky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma As, Olga Sakova, Ruzena Sochorova, Ivan Varga, Mikulas Lehocky filed Critical Slovakofarma As
Priority to AU2003216034A priority Critical patent/AU2003216034A1/en
Publication of WO2003059297A2 publication Critical patent/WO2003059297A2/en
Publication of WO2003059297A3 publication Critical patent/WO2003059297A3/en
Publication of WO2003059297A8 publication Critical patent/WO2003059297A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Dermatological topical compositions, which contain, as the active substance, at least one substance from the group including bifonazole, zincpyrithione, piroctone olamine, sulfoconcentrol, or a mixture of some of the said active substances, alpantha and auxiliary substances, and a process of preparation, in which a viscous topical liquid having antimycotic effect is prepared, which is destined for use in the treatment of the skin fungal infections caused by moulds and yeasts.
PCT/SK2003/000002 2002-01-21 2003-01-17 Dermatological topical compositions and a process for the preparation thereof WO2003059297A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003216034A AU2003216034A1 (en) 2002-01-21 2003-01-17 Dermatological topical compositions and a process for the preparation thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK103022002 2002-01-21
SKPP0103-02 2002-01-21

Publications (3)

Publication Number Publication Date
WO2003059297A2 WO2003059297A2 (en) 2003-07-24
WO2003059297A3 WO2003059297A3 (en) 2003-12-18
WO2003059297A8 true WO2003059297A8 (en) 2004-04-15

Family

ID=20436044

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SK2003/000002 WO2003059297A2 (en) 2002-01-21 2003-01-17 Dermatological topical compositions and a process for the preparation thereof

Country Status (2)

Country Link
AU (1) AU2003216034A1 (en)
WO (1) WO2003059297A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018085A2 (en) * 2006-08-10 2008-02-14 Naveh Pharma (1996) Ltd. Compositions and methods for treating dermatological abscesses
GB0715141D0 (en) * 2007-08-03 2007-09-12 York Pharma Plc Improving skin barrier function
EP2222319A2 (en) * 2007-11-17 2010-09-01 Bayer Consumer Care AG Topical drugs for use in antifungal therapy
DE102010013275A1 (en) * 2010-03-29 2011-09-29 Beiersdorf Ag Microbiologically stable, application-friendly W / O preparations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227164A (en) * 1990-01-29 1993-07-13 Lundmark Larry D Hair treatment composition and method
CA2226907A1 (en) * 1995-07-14 1997-02-06 Paul Anthony Bowser Antimicrobial hair treatment composition
DE19537509A1 (en) * 1995-09-27 1997-04-10 Egsto Pharm Pharmazeutische Pr Prods. for treating irritated skin
BR9810396A (en) * 1997-07-02 2000-09-05 Neutrogena Corp Processes for using compositions containing dichlorophenyl imidazoldioxolane to treat seborrheic dermatitis, dandruff, psoriasis and acne, and compositions thereof
US6099870A (en) * 1997-12-18 2000-08-08 Johnson & Johnson Consumer Companies, Inc. Methods for improving the health of hair and scalp
US6437978B1 (en) * 1998-12-04 2002-08-20 Sony Corporation Cooling device, cooling method, and electronic apparatus
DE19916334A1 (en) * 1999-04-12 2000-10-19 Schwarzkopf Gmbh Hans Cosmetic agent and use
US6974569B2 (en) * 1999-05-03 2005-12-13 The Procter & Gamble Company Shampoos providing a superior combination anti-dandruff efficacy and condition
FR2795955A1 (en) * 1999-07-09 2001-01-12 Oreal Composition for treatment of dandruff contains antidandruff agent and amino fructane
FR2798848B1 (en) * 1999-09-29 2001-12-28 Oreal ANTI-DANDRUFF TREATMENT COMPOSITION FOR HAIR AND SCALP, BASED ON A PYRIDINETHIONE SALT, AN INSOLUBLE CONDITIONING AGENT AND AN ACRYLIC TERPOLYMER
JP3371098B2 (en) * 1999-11-04 2003-01-27 花王株式会社 Detergent composition
DE19961278A1 (en) * 1999-12-18 2001-06-21 Cognis Deutschland Gmbh Use of nanoscale antidandruff agents
IL133760A (en) * 1999-12-28 2007-10-31 Pharmaskin Ltd Composition for the treatment of dandruff
US6635702B1 (en) * 2000-04-11 2003-10-21 Noveon Ip Holdings Corp. Stable aqueous surfactant compositions
GB0015723D0 (en) * 2000-06-27 2000-08-16 Unilever Plc Compositions containing a metal pyrithione
MXPA03003132A (en) * 2000-10-10 2003-07-14 Procter & Gamble Packaged scalp cosmetic compositions.

Also Published As

Publication number Publication date
AU2003216034A1 (en) 2003-07-30
AU2003216034A8 (en) 2003-07-30
WO2003059297A2 (en) 2003-07-24
WO2003059297A3 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2005000241A3 (en) Compositons and methods for topical administration
WO2009032773A3 (en) Compositions and methods for treating demodex infestations
EP1570840A3 (en) Topical composition comprising n-acetylaldosamines or n-acetylamino acids
WO2003066001A3 (en) Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
WO2005034883A3 (en) A method of healing skin wounds in mammals and a composition therefor
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
WO2005000248A3 (en) Compositions and methods for skin conditioning
WO2004000227A3 (en) Use of thio-oxindole derivatives in treatment of skin disorders
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2003066597A3 (en) Guanidino compounds
WO2004009038A3 (en) Cosmetic preparations with antibacterial properties comprising glycyrrhetinic acid
CA2368165A1 (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2003015724A1 (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
WO2001085139A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2005058934A3 (en) Glycosylated steroid derivatives with anti-migratory activity
WO2003059297A8 (en) Dermatological topical compositions and a process for the preparation thereof
WO2007082864A3 (en) Use of chavicol as an antiseptic
WO2005065713A3 (en) Topically applied medicament for animals
CA2505500A1 (en) Method of stimulating hair growth using benzopyrans
WO2002055022A3 (en) Active metabolite of antifungal compound
AU2904700A (en) Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa
ATE424896T1 (en) DEPIGMENTIZING OR WHITENING COSMETIC COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE AS AN ACTIVE INGREDIENT

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PV2003-3120

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: PV2003-3120

Country of ref document: CZ

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 30/2003 UNDER (72, 75) THE NAME SHOULD READ "VARGA, IVAN"

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP